Table 6 Multivariate Cox proportional hazards model for analysis of survival in HBsAg-positive DLBCL patients
Factors | HR | 95% CI | P value | |
|---|---|---|---|---|
Lower | Upper | |||
Age/year | Â | Â | Â | Â |
 > 60 | 1.940 | 0.528 | 7.132 | 0.319 |
 ≤ 60 | 1 | - | - |  |
Ann Arbor stage | Â | Â | Â | Â |
 I–II | 1 | – | – | 0.532 |
 III–IV | 1.500 | 0.421 | 5.337 |  |
B-symtoms | Â | Â | Â | Â |
 Yes | 1.969 | 0.565 | 6.860 | 0.287 |
 No | 1 | – | – |  |
Elevated LDH | Â | Â | Â | Â |
 Yes | 1.345 | 0.448 | 4.037 | 0.598 |
 No | 1 | – | – |  |
Treated with rituximab | Â | Â | Â | Â |
 Yes | 0.294 | 0.102 | 0.843 | 0.023 |
 No | 1 | – | – |  |
Spleen involvement | Â | Â | Â | Â |
 Yes | 3.725 | 1.444 | 9.614 | 0.007 |
 No | 1 | – | - |  |
Bcl-2&Myc Positive | Â | Â | Â | Â |
 Yes | 2.270 | 0.879 | 5.862 | 0.090 |
 No | 1 | – | – |  |